top of page

FDA Adds “Guillain-Barré Syndrome” Warning to Johnson & Johnson Covid Vaccine

The FDA on Monday announced it will be adding an advisory to Johnson & Johnson’s Covid-19 vaccine warning about Guillain-Barré Syndrome as a possible adverse side effect.









4 views0 comments

Comments


bottom of page